Low Dose Radiation in Childhood Non-Hodgkin's Lymphoma
Author Information
Author(s): M.G. Mott, O.B. Eden, M.K. Palmer
Primary Institution: United Kingdom Children's Cancer Study Group
Hypothesis
Does adjuvant low dose radiation improve outcomes in children with non-Hodgkin's lymphoma when combined with chemotherapy?
Conclusion
Combination chemotherapy should be the primary treatment for childhood non-Hodgkin's lymphoma, as low dose radiation did not show a benefit.
Supporting Evidence
- Failure-free survival at 4 years was 74% for localized disease and 51% for generalized disease.
- Patients with mediastinal primaries continued to relapse after treatment.
- FFS for patients with non-mediastinal primaries was 65%.
Takeaway
This study looked at kids with a type of cancer called non-Hodgkin's lymphoma and found that giving them extra radiation after chemotherapy didn't help them get better.
Methodology
A randomized trial comparing combination chemotherapy and low dose radiation in children with non-Hodgkin's lymphoma.
Potential Biases
Potential bias due to varying treatment protocols across different centers.
Limitations
The study was limited by the small sample size and the exclusion of patients with certain conditions.
Participant Demographics
97 boys and 23 girls, aged 2-14 years.
Statistical Information
P-Value
0.1
Statistical Significance
p=0.05
Want to read the original?
Access the complete publication on the publisher's website